# Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer

> **NCT01839994** · PHASE3 · UNKNOWN · sponsor: **Maria Sklodowska-Curie National Research Institute of Oncology** · enrollment: 350 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** CF-CRT combined with BT or SBRT boost.
- **RADIATION:** CF-CRT alone
- **DRUG:** Hormonal treatment (neoadjuvant androgen deprivation)

## Key facts

- **NCT ID:** NCT01839994
- **Lead sponsor:** Maria Sklodowska-Curie National Research Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2016-12
- **Final completion:** 2018-12
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2013-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01839994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01839994, "Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01839994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*